FLORENCE: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk
Titel:
FLORENCE: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk
Auteur:
Spina, M. Nagy, Z. Ribera, J.M. Federico, M. Aurer, I. Jordan, K. Borsaru, G. Pristupa, A.S. Bosi, A. Grosicki, S. Glushko, N.L. Ristic, D. Jakucs, J. Montesinos, P. Mayer, J. Rego, E.M. Baldini, S. Scartoni, S. Capriati, A. Maggi, C.A. Simonelli, C.